Enoxamed Study in the Treatment of Acute Coronary Syndromes

NCT02152423 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: LOVENOX
DRUG: ENOXAMED

Sponsor

University of Monastir

Collaborators

[object Object]